CRYO-CELL INTL INC (CCEL) Fundamental Analysis & Valuation
NYSEARCA:CCEL • US2288951088
Current stock price
3.58 USD
+0.02 (+0.56%)
Last:
This CCEL fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. CCEL Profitability Analysis
1.1 Basic Checks
- In the past year CCEL has reported negative net income.
- CCEL had a positive operating cash flow in the past year.
- The reported net income has been mixed in the past 5 years: CCEL reported negative net income in multiple years.
- In the past 5 years CCEL always reported a positive cash flow from operatings.
1.2 Ratios
- CCEL has a Return On Assets (-0.75%) which is comparable to the rest of the industry.
- With a decent Return On Invested Capital value of 7.64%, CCEL is doing good in the industry, outperforming 72.00% of the companies in the same industry.
- CCEL had an Average Return On Invested Capital over the past 3 years of 8.32%. This is in line with the industry average of 8.51%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.75% | ||
| ROE | N/A | ||
| ROIC | 7.64% |
ROA(3y)-6.29%
ROA(5y)-2.23%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)8.32%
ROIC(5y)8.46%
1.3 Margins
- CCEL has a Operating Margin of 13.63%. This is amongst the best in the industry. CCEL outperforms 86.00% of its industry peers.
- In the last couple of years the Operating Margin of CCEL has declined.
- The Gross Margin of CCEL (77.07%) is better than 92.00% of its industry peers.
- In the last couple of years the Gross Margin of CCEL has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 13.63% | ||
| PM (TTM) | N/A | ||
| GM | 77.07% |
OM growth 3Y4.95%
OM growth 5Y-11.79%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.57%
GM growth 5Y2.12%
2. CCEL Health Analysis
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CCEL is destroying value.
- CCEL has less shares outstanding than it did 1 year ago.
- CCEL has more shares outstanding than it did 5 years ago.
- CCEL has a worse debt/assets ratio than last year.
2.2 Solvency
- Based on the Altman-Z score of 0.05, we must say that CCEL is in the distress zone and has some risk of bankruptcy.
- CCEL has a worse Altman-Z score (0.05) than 76.00% of its industry peers.
- The Debt to FCF ratio of CCEL is 1.36, which is an excellent value as it means it would take CCEL, only 1.36 years of fcf income to pay off all of its debts.
- The Debt to FCF ratio of CCEL (1.36) is better than 82.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 1.36 | ||
| Altman-Z | 0.05 |
ROIC/WACC0.64
WACC11.99%
2.3 Liquidity
- A Current Ratio of 0.63 indicates that CCEL may have some problems paying its short term obligations.
- Looking at the Current ratio, with a value of 0.63, CCEL is doing worse than 86.00% of the companies in the same industry.
- CCEL has a Quick Ratio of 0.63. This is a bad value and indicates that CCEL is not financially healthy enough and could expect problems in meeting its short term obligations.
- With a Quick ratio value of 0.60, CCEL is not doing good in the industry: 83.00% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.63 | ||
| Quick Ratio | 0.6 |
3. CCEL Growth Analysis
3.1 Past
- The earnings per share for CCEL have decreased strongly by -1750.00% in the last year.
- The Revenue has decreased by -1.31% in the past year.
- Measured over the past years, CCEL shows a small growth in Revenue. The Revenue has been growing by 0.27% on average per year.
EPS 1Y (TTM)-1750%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-66.67%
Revenue 1Y (TTM)-1.31%
Revenue growth 3Y1.33%
Revenue growth 5Y0.27%
Sales Q2Q%-3.59%
3.2 Future
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y123.03%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-3.55%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. CCEL Valuation Analysis
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for CCEL. In the last year negative earnings were reported.
- With a Price/Forward Earnings ratio of 50.14, CCEL can be considered very expensive at the moment.
- CCEL's Price/Forward Earnings is on the same level as the industry average.
- Compared to an average S&P500 Price/Forward Earnings ratio of 38.88, CCEL is valued a bit more expensive.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 50.14 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, CCEL is valued cheaply inside the industry as 93.00% of the companies are valued more expensively.
- 95.00% of the companies in the same industry are more expensive than CCEL, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 4.67 | ||
| EV/EBITDA | 5.81 |
4.3 Compensation for Growth
- The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. CCEL Dividend Analysis
5.1 Amount
- CCEL has a Yearly Dividend Yield of 11.24%, which is a nice return.
- Compared to an average industry Dividend Yield of 0.47, CCEL pays a better dividend. On top of this CCEL pays more dividend than 100.00% of the companies listed in the same industry.
- Compared to an average S&P500 Dividend Yield of 1.81, CCEL pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 11.24% |
5.2 History
- CCEL has been paying a dividend for less than 5 years, so it still needs to build a track record.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
5.3 Sustainability
- CCEL has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-1109.12%
EPS Next 2YN/A
EPS Next 3YN/A
CCEL Fundamentals: All Metrics, Ratios and Statistics
NYSEARCA:CCEL (4/22/2026, 8:12:21 PM)
3.58
+0.02 (+0.56%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)04-14 2026-04-14/amc
Earnings (Next)07-13 2026-07-13
Inst Owners12.47%
Inst Owner Change-41.71%
Ins Owners41.98%
Ins Owner Change0.79%
Market Cap28.85M
Revenue(TTM)31.57M
Net Income(TTM)-473.50K
Analysts43.33
Price Target8.67 (142.18%)
Short Float %0.26%
Short Ratio0.78
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 11.24% |
Yearly Dividend0.4
Dividend Growth(5Y)N/A
DP-1109.12%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)227.45%
Min EPS beat(2)178.43%
Max EPS beat(2)276.47%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-3.61%
Min Revenue beat(2)-3.88%
Max Revenue beat(2)-3.33%
Revenue beat(4)0
Avg Revenue beat(4)-2.41%
Min Revenue beat(4)-3.88%
Max Revenue beat(4)-0.9%
Revenue beat(8)0
Avg Revenue beat(8)-2.16%
Revenue beat(12)2
Avg Revenue beat(12)-0.97%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)116.67%
EPS NY rev (3m)116.67%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)1.39%
Revenue NY rev (3m)1.39%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 50.14 | ||
| P/S | 0.91 | ||
| P/FCF | 4.67 | ||
| P/OCF | 4.54 | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | 5.81 |
EPS(TTM)-0.33
EYN/A
EPS(NY)0.07
Fwd EY1.99%
FCF(TTM)0.77
FCFY21.43%
OCF(TTM)0.79
OCFY22.02%
SpS3.94
BVpS-1.84
TBVpS-2.19
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.75% | ||
| ROE | N/A | ||
| ROCE | 9.68% | ||
| ROIC | 7.64% | ||
| ROICexc | 8.24% | ||
| ROICexgc | 8.84% | ||
| OM | 13.63% | ||
| PM (TTM) | N/A | ||
| GM | 77.07% | ||
| FCFM | 19.48% |
ROA(3y)-6.29%
ROA(5y)-2.23%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)8.32%
ROIC(5y)8.46%
ROICexc(3y)8.86%
ROICexc(5y)9.39%
ROICexgc(3y)9.56%
ROICexgc(5y)10.26%
ROCE(3y)10.53%
ROCE(5y)10.71%
ROICexgc growth 3Y10.58%
ROICexgc growth 5Y-24.53%
ROICexc growth 3Y10.79%
ROICexc growth 5Y-22.99%
OM growth 3Y4.95%
OM growth 5Y-11.79%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.57%
GM growth 5Y2.12%
F-Score7
Asset Turnover0.5
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 1.36 | ||
| Debt/EBITDA | 1.54 | ||
| Cap/Depr | 17.31% | ||
| Cap/Sales | 0.54% | ||
| Interest Coverage | 2.13 | ||
| Cash Conversion | 119.5% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.63 | ||
| Quick Ratio | 0.6 | ||
| Altman-Z | 0.05 |
F-Score7
WACC11.99%
ROIC/WACC0.64
Cap/Depr(3y)286.14%
Cap/Depr(5y)369.56%
Cap/Sales(3y)10.02%
Cap/Sales(5y)15.31%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1750%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-66.67%
EPS Next Y123.03%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-1.31%
Revenue growth 3Y1.33%
Revenue growth 5Y0.27%
Sales Q2Q%-3.59%
Revenue Next Year-3.55%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-5.52%
EBIT growth 3Y6.35%
EBIT growth 5Y-11.56%
EBIT Next Year1.6%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y100.23%
FCF growth 3YN/A
FCF growth 5Y-8.91%
OCF growth 1Y-11.72%
OCF growth 3Y-13.86%
OCF growth 5Y-8.34%
CRYO-CELL INTL INC / CCEL Fundamental Analysis FAQ
Can you provide the ChartMill fundamental rating for CRYO-CELL INTL INC?
ChartMill assigns a fundamental rating of 3 / 10 to CCEL.
What is the valuation status of CRYO-CELL INTL INC (CCEL) stock?
ChartMill assigns a valuation rating of 4 / 10 to CRYO-CELL INTL INC (CCEL). This can be considered as Fairly Valued.
What is the profitability of CCEL stock?
CRYO-CELL INTL INC (CCEL) has a profitability rating of 4 / 10.
Can you provide the financial health for CCEL stock?
The financial health rating of CRYO-CELL INTL INC (CCEL) is 3 / 10.